Ovarian fibroma thecoma with serous cystadenoma-an unusual combination in young patient: a case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20241970Keywords:
Ovarian firboma thecoma, Ovarian serous cystadenoma, Ovarian mass in young age, Composite ovarian tumor, Ovarian torsionAbstract
The article is a case report of a 16-year-old patient who came to tertiary care centre in western part of India with a case of ovarian tumor with torsion. The ovarian mass was a composite tumor of ovarian thecoma fibroma and serous cystadenoma. The detection of ovarian mass was made with ultrasonography and CT scan. Her tumor markers were not raised. The patient was managed surgically with ovarian mass removal along with removal of non-salvageable ovary. The present literature has very few cases of ovarian thecoma fibroma with serous cystadenoma and there is no such case occurring at a young age of 16 years. Such a case needs to be kept in mind when dealing with ovarian masses in young age as a solid mass with a cystic tumor may raise a suspicion of malignancy in preliminary evaluation. Also, further evaluation is necessary as to occurrence of such composite tumors and that too in younger age groups.
Metrics
References
Parwate NS, Patel SM, Arora R, Gupta M. Ovarian fibroma: A clinico-pathological study of 23 cases with review of literature. J Obstet Gynaecol India. 2016;66(6):460-5.
Cho YJ, Lee HS, Kim JM, Joo KY, Kim M-L. Clinical characteristics and surgical management options for ovarian fibroma/fibrothecoma: A study of 97 cases. Gynecol Obstet Invest. 2013;76(3):182-7.
Chen H, Liu Y, Shen L-F, Jiang M-J, Yang Z-F, Fang G-P. Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison. J Ovarian Res. 2016;9(1):1.
Jayalakshmy PS, Poothiode U, Krishna G, Jayalakshmy PL. Ovarian fibroma with serous cystadenoma-an unusual combination: A case report. Case Rep Obstet Gynecol. 2012;2012:1-3.
Balhara K, Mallya V, Khurana N, Tempe A. Coexisting ovarian serous cystadenoma with fibroma: A very unusual combination. J Cancer Res Ther. 2023;19(5):1474-6.